// App-Quantinova.ai

2971 : Safety, Feasibility and Cost Of Hematopoietic Stem Cell Transplantation Management By Peripheral Inserted Central Catheter (PICC): A Phase II Prospective Study

Researchers

Presenter

  • Daniele Derudas

Principal Investigators

  • Donatella Baronciani

  • Cristina Depau

  • Federica Pilo

  • Clara Targhetta

  • Sara Veronica Usai

  • Giuseppe Longhitano

  • Daniela Ibba

  • Emanuele Angelucci

Medical Centers

  • UO Ematologia e CTMO Ospedale Oncologico A. Businco, Cagliari, Italy

  • Hematology and Transplant Center, Ospedale Oncologico di Riferimento Regionale Armando Businco , Cagliari, Italy

  • Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico Armando Businco, Cagliari, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Multiple Myeloma

  • Sepsis

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • Bendamustine

  • Hydroxyzine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved